factor

(redirected from Granulocyte colony-stimulating factor)
Also found in: Dictionary, Medical, Legal, Financial, Encyclopedia, Wikipedia.
Related to Granulocyte colony-stimulating factor: GCFS, rhG-CSF
  • all
  • noun
  • verb

Synonyms for factor

Synonyms for factor

one of the individual entities contributing to a whole

one of the conditions or facts attending an event and having some bearing on it

Synonyms for factor

one of two or more integers that can be exactly divided into another integer

any of the numbers (or symbols) that form a product when multiplied together

an independent variable in statistics

be a contributing factor

consider as relevant when making a decision

References in periodicals archive ?
Administration of granulocyte colony-stimulating factor enhances endothelialization and microvessel formation in small calib re synthetic vascular grafts.
Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression.
In my opinion, you can reduce the interferon dosage after early virologic response is achieved; at that point, I would argue that you could drop the granulocyte colony-stimulating factor (G-CSF).
The Granulocyte colony-stimulating factor (G-CSF) biologics/biosimilars stimulate the production of neutrophils.
Dense dosing is made possible by prophylactic administration of granulocyte colony-stimulating factor (filgrastim) to prevent severe neutropenia.
F-627 is a newer generation recombinant human granulocyte colony-stimulating factor (G-CSF) that helps the cancer patients to recover from chemotherapy induced neutropenia, a potentially life threatening condition.
The Orphan Drug Designation was granted for use of BL-8040, in combination with granulocyte colony-stimulating factor (G-CSF), to mobilize human stem cells from the bone marrow to the peripheral blood for collection for autologous or allogeneic (donor-based) transplantation.
Combined sales of granulocyte colony-stimulating factors (G-CSFs) (Amgen's Neupogen [filgrastim] and Neulasta [pegfilgrastim]) were approximately $4.
For the purpose of this report, the biosimilars market is categorized into, erythropoietins, human growth hormone (HGH), granulocyte colony-stimulating factors (G-CSF), low-molecular-weight heparins (LMWH) and other biosimilars.
human growth hormone, granulocyte colony-stimulating factors and erythropoiesis-stimulating agents) have been available in Europe for several years, overall biosimilars sales remain relatively modest.
An analysis of 14 randomized clinical trials demonstrate that granulocyte colony-stimulating factors (G-CSFs) administered in the first and subsequent cycles of chemotherapy reduce the incidence of febrile neutropenia (low white blood cell count with fever) and infection-related mortality in cancer patients.
Full browser ?